Christopher B. Ehrlich - 04 Mar 2025 Form 4 Insider Report for CERO THERAPEUTICS HOLDINGS, INC. (CERO)

Role
Chairman and CEO, Director
Signature
/s/ Christopher B. Ehrlich
Issuer symbol
CERO
Transactions as of
04 Mar 2025
Transactions value $
$0
Form type
4
Filing time
06 Mar 2025, 16:10:56 UTC
Previous filing
26 Feb 2025
Next filing
02 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CERO Stock Option (Right to Buy) Award $0 +119,486 $0 119,486 04 Mar 2025 Common Stock 119,486 $1.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the 50% time-based portion of an award of options to purchase 238,971 shares, vesting on the nine month anniversary of the grant date, with the remaining portion subject to performance conditions.